Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Adrián Alonso Ruiz, Anna Bezruki, Erika Shinabargar, Kaitlin Large, Marcela Vieira, Iulia Slovenski, Yiqi Liu, Surabhi Agarwal, Anna Becker, Suerie Moon
BACKGROUND: Unequal and inequitable access to Covid-19 vaccines in low- and middle-income countries (L&MICs) was a major political, ethical and public health failure in the pandemic. However, vaccine developers' practices were not monolithic, but rather, took diverse approaches to supplying different countries, with important implications for global access. RESULTS: Using data on R&D investments, regulatory approvals, manufacturing and purchase agreements, and vaccine deliveries, we identified six distinct innovation models that apply across the 14 COVID-19 vaccines with more international presence from 2020-2022...
March 26, 2024: Globalization and Health
#2
JOURNAL ARTICLE
Marcela Vieira, Tatiana Andia, Obaida Karim, Sanjida Ahmed Srishti, Sebastian Alfonso Pineda, Adrian Alonso Ruiz, Kaitlin Large, Yiqi Liu, Suerie Moon, Nahitun Naher, Azizah Siddiqui, Syed Masud Ahmed
BACKGROUND: There is growing interest in pharmaceutical innovation in low- and middle-income countries (LMICs), but information on existing activities, capacities, and outcomes is scarce. We mapped available data at the global level, and studied the national pharmaceutical innovation systems of Bangladesh and Colombia to shed light on pharmaceutical research and development (R&D) in the Global South, including challenges and prospects, to help fill existing knowledge gaps. METHODS: We gathered and analyzed data from three types of sources: literature, semi-structured interviews with key informants, and publicly available data on R&D funding, R&D scientific capacity measured by human resources, and clinical trial activities...
November 27, 2023: Journal of Pharmaceutical Policy and Practice
#3
REVIEW
Irene Agyepong, Neil Spicer, Gorik Ooms, Albrecht Jahn, Till Bärnighausen, Claudia Beiersmann, Hannah Brown Amoakoh, Günter Fink, Yan Guo, Lisa Hennig, Mahlet Kifle Habtemariam, Bocar A Kouyaté, Rene Loewenson, Angela Micah, Suerie Moon, Mosa Moshabela, Sonja Lynn Myhre, Trygve Ottersen, Walaiporn Patcharanarumol, Malabika Sarker, Gita Sen, Yasuhisa Siozaki, Francisco Songane, Devi Sridhar, Freddie Ssengooba, Jeanette Vega, Deisy Ventura, Maike Voss, David Heymann
No abstract text is available yet for this article.
May 18, 2023: Lancet
#4
JOURNAL ARTICLE
Christine Årdal, Enrico Baraldi, Reinhard Busse, Rosa Castro, Francesco Ciabuschi, José Miguel Cisneros, Inge C Gyssens, Stephan Harbarth, Tomislav Kostyanev, Yohann Lacotte, Nicola Magrini, Anthony McDonnell, Annelie A Monnier, Suerie Moon, Elias Mossialos, Germán Peñalva, Marie-Cécile Ploy, Momir Radulović, Adrián Alonso Ruiz, John-Arne Røttingen, Michael Sharland, Evelina Tacconelli, Ursula Theuretzbacher, Sabine Vogler, Ute Wolff Sönksen, Kerstin Åkerfeldt, Otto Cars, Jim O'Neill
No abstract text is available yet for this article.
February 9, 2023: Lancet
#5
Soumya Swaminathan, Bernard Pécoul, Hisham Abdullah, Christos Christou, Glenda Gray, Carel IJsselmuiden, Marie Paule Kieny, Mariana Mazzucato, Veronika von Messling, Bernhards Ogutu, John Reeder, John-Arne Røttingen, Renu Swarup, Marcel Tanner, Nísia Trindade Lima, Michelle Childs, Alex Harris, Els Torreele, Suerie Moon
No abstract text is available yet for this article.
February 2022: Nature
#6
REVIEW
Suerie Moon, Jana Armstrong, Brian Hutler, Ross Upshur, Rachel Katz, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, Ruth Faden, Prakash Ghimire, Dirceu Greco, Calvin Wl Ho, Sonali Kochhar, G Owen Schaefer, Ehsan Shamsi-Gooshki, Jerome Amir Singh, Maxwell J Smith, Jonathan Wolff
The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international effort to achieve equitable access to COVID-19 health technologies, and its governance is a matter of broad public importance. We traced the evolution of ACT-A's governance through publicly available documents and analysed it against three principles embedded in the founding mission statement of ACT-A: participation, transparency, and accountability...
January 29, 2022: Lancet
#7
EDITORIAL
Suerie Moon, Surabhi Agarwal, Anna Becker, Adrian Alonso Ruiz
No abstract text is available yet for this article.
September 20, 2021: BMJ: British Medical Journal
#8
JOURNAL ARTICLE
Suerie Moon, Adrián Alonso Ruiz, Marcela Vieira
New England Journal of Medicine, Volume 385, Issue 3, Page 193-196, July 2021.
July 15, 2021: New England Journal of Medicine
#9
JOURNAL ARTICLE
Anna Bezruki, Suerie Moon
No abstract text is available yet for this article.
May 19, 2021: BMJ: British Medical Journal
#10
JOURNAL ARTICLE
Suerie Moon, Ilona Kickbusch
No abstract text is available yet for this article.
May 5, 2021: Lancet. Public Health
#11
JOURNAL ARTICLE
Marcela Vieira, Ryan Kimmitt, Suerie Moon
Background: The past two decades have witnessed significant growth in non-commercial research and development (R&D) initiatives, particularly for neglected diseases, but there is limited understanding of the ways in which they compare with traditional commercial R&D. This study analyses costs, timeframes, and attrition rates of non-commercial R&D across multiple initiatives and how they compare to commercial R&D using the Portfolio-to-Impact (P2I) model as parameter of comparison. Methods: This is a mixed-method, observational, descriptive and analytic study...
2021: F1000Research
#12
JOURNAL ARTICLE
Jorge Vinuales, Suerie Moon, Ginevra Le Moli, Gian-Luca Burci
No abstract text is available yet for this article.
April 28, 2021: Lancet
#13
JOURNAL ARTICLE
Ria Vaidya, Asha Herten-Crabb, Julia Spencer, Suerie Moon, Louis Lillywhite
BACKGROUND: A key purpose of the IHR is to prevent unwarranted interruptions to trade and travel during large and/or transnational infectious disease outbreaks. Nevertheless, such outbreaks continue to disrupt the travel industry. This aspect of the IHR has received little attention in the academic literature despite its considerable impact on affected States and commercial activity. This paper outlines the challenges and gaps in knowledge regarding the relationship between outbreaks and the travel sector and discusses the opportunities for further research and policy work to overcome these challenges...
April 16, 2020: Journal of Travel Medicine
#14
JOURNAL ARTICLE
Suerie Moon, Stephanie Mariat, Isao Kamae, Hanne Bak Pedersen
No abstract text is available yet for this article.
January 13, 2020: BMJ: British Medical Journal
#15
JOURNAL ARTICLE
Fatima Suleman, Marcus Low, Suerie Moon, Steven G Morgan
No abstract text is available yet for this article.
January 13, 2020: BMJ: British Medical Journal
#16
JOURNAL ARTICLE
Steven G Morgan, Hannah S Bathula, Suerie Moon
No abstract text is available yet for this article.
January 13, 2020: BMJ: British Medical Journal
#17
REVIEW
Michael J A Reid, Nimalan Arinaminpathy, Amy Bloom, Barry R Bloom, Catharina Boehme, Richard Chaisson, Daniel P Chin, Gavin Churchyard, Helen Cox, Lucica Ditiu, Mark Dybul, Jeremy Farrar, Anthony S Fauci, Endalkachew Fekadu, Paula I Fujiwara, Timothy B Hallett, Christy L Hanson, Mark Harrington, Nick Herbert, Philip C Hopewell, Chieko Ikeda, Dean T Jamison, Aamir J Khan, Irene Koek, Nalini Krishnan, Aaron Motsoaledi, Madhukar Pai, Mario C Raviglione, Almaz Sharman, Peter M Small, Soumya Swaminathan, Zelalem Temesgen, Anna Vassall, Nandita Venkatesan, Kitty van Weezenbeek, Gavin Yamey, Bruce D Agins, Sofia Alexandru, Jason R Andrews, Naomi Beyeler, Stela Bivol, Grania Brigden, Adithya Cattamanchi, Danielle Cazabon, Valeriu Crudu, Amrita Daftary, Puneet Dewan, Laurie K Doepel, Robert W Eisinger, Victoria Fan, Sara Fewer, Jennifer Furin, Jeremy D Goldhaber-Fiebert, Gabriela B Gomez, Stephen M Graham, Devesh Gupta, Maureen Kamene, Sunil Khaparde, Eunice W Mailu, Enos O Masini, Lorrie McHugh, Ellen Mitchell, Suerie Moon, Michael Osberg, Tripti Pande, Lea Prince, Kirankumar Rade, Raghuram Rao, Michelle Remme, James A Seddon, Casey Selwyn, Priya Shete, Kuldeep S Sachdeva, Guy Stallworthy, Juan F Vesga, Valentina Vilc, Eric P Goosby
No abstract text is available yet for this article.
March 30, 2019: Lancet
#18
JOURNAL ARTICLE
Suerie Moon, Elise Erickson
High prices can restrict access to medicines in rich and poor countries alike. Australia’s approach to providing direct-acting antivirals (DAAs) for patients with hepatitis C virus (HCV) suggests that, under certain conditions, innovative approaches to payment can remove price as a barrier to..
February 14, 2019: New England Journal of Medicine
#19
JOURNAL ARTICLE
Jennifer Leigh, Gabrielle Fitzgerald, Elvis Garcia, Suerie Moon
No abstract text is available yet for this article.
August 9, 2018: BMJ: British Medical Journal
#20
EDITORIAL
Suerie Moon
No abstract text is available yet for this article.
February 26, 2018: BMJ: British Medical Journal
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
